Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
Alimentary Pharmacology & Therapeutics
|
November 13, 2015
Longitudinal assessment of hepatitis C fibrosis progression by collagen and smooth muscle actin morphometry in comparison to serum markers
K Patel, H L Tillmann, B Matta, et al.
Lancet (London, England)
|
October 5, 2001
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
M P Manns, J G McHutchison, S C Gordon, et al.
Journal of Hepatology
|
December 12, 2001
Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B
Y O Kweon, Z D Goodman, J L Dienstag, et al.
Hepatology (Baltimore, Md.)
|
April 16, 1998
Combination therapy with thymosin alpha1 and interferon for the treatment of chronic hepatitis C infection: a randomized, placebo-controlled double-blind trial
K E Sherman, M Sjogren, R L Creager, et al.
AJR. American Journal of Roentgenology
|
May 1, 1986
Thorotrast-induced hepatosplenic neoplasia: CT identification
D W Levy, S Rindsberg, A C Friedman, et al.
The New England Journal of Medicine
|
November 20, 1998
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group
J G McHutchison, S C Gordon, E R Schiff, et al.
Hepatology (Baltimore, Md.)
|
August 2, 2001
A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C
K L Lindsay, C Trepo, T Heintges, et al.
Journal of Clinical Pathology
|
January 22, 2009
Is histological diagnosis of primary liver carcinomas with fibrous stroma reproducible among experts?
G Malouf, B Falissard, D Azoulay, et al.
Hepatology (Baltimore, Md.)
|
February 15, 2001
Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study
L B Seeff, F B Hollinger, H J Alter, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
Alimentary Pharmacology & Therapeutics
|
November 13, 2015
Longitudinal assessment of hepatitis C fibrosis progression by collagen and smooth muscle actin morphometry in comparison to serum markers
K Patel, H L Tillmann, B Matta, et al.
Lancet (London, England)
|
October 5, 2001
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
M P Manns, J G McHutchison, S C Gordon, et al.
Journal of Hepatology
|
December 12, 2001
Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B
Y O Kweon, Z D Goodman, J L Dienstag, et al.
Hepatology (Baltimore, Md.)
|
April 16, 1998
Combination therapy with thymosin alpha1 and interferon for the treatment of chronic hepatitis C infection: a randomized, placebo-controlled double-blind trial
K E Sherman, M Sjogren, R L Creager, et al.
AJR. American Journal of Roentgenology
|
May 1, 1986
Thorotrast-induced hepatosplenic neoplasia: CT identification
D W Levy, S Rindsberg, A C Friedman, et al.
The New England Journal of Medicine
|
November 20, 1998
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group
J G McHutchison, S C Gordon, E R Schiff, et al.
Hepatology (Baltimore, Md.)
|
August 2, 2001
A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C
K L Lindsay, C Trepo, T Heintges, et al.
Journal of Clinical Pathology
|
January 22, 2009
Is histological diagnosis of primary liver carcinomas with fibrous stroma reproducible among experts?
G Malouf, B Falissard, D Azoulay, et al.
Hepatology (Baltimore, Md.)
|
February 15, 2001
Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study
L B Seeff, F B Hollinger, H J Alter, et al.
Page
of 8